Predicting the risk of a false-positive test for women following a mammography screening programme.

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Predicting the risk of a false-positive test for women following a mammography screening programme. / Njor, Sisse Helle; Olsen, Anne Helene; Schwartz, Walter; Vejborg, Ilse; Lynge, Elsebeth.

In: Journal of Medical Screening, Vol. 14, No. 2, 2007, p. 94-7.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Njor, SH, Olsen, AH, Schwartz, W, Vejborg, I & Lynge, E 2007, 'Predicting the risk of a false-positive test for women following a mammography screening programme.', Journal of Medical Screening, vol. 14, no. 2, pp. 94-7. https://doi.org/10.1258/096914107781261891

APA

Njor, S. H., Olsen, A. H., Schwartz, W., Vejborg, I., & Lynge, E. (2007). Predicting the risk of a false-positive test for women following a mammography screening programme. Journal of Medical Screening, 14(2), 94-7. https://doi.org/10.1258/096914107781261891

Vancouver

Njor SH, Olsen AH, Schwartz W, Vejborg I, Lynge E. Predicting the risk of a false-positive test for women following a mammography screening programme. Journal of Medical Screening. 2007;14(2):94-7. https://doi.org/10.1258/096914107781261891

Author

Njor, Sisse Helle ; Olsen, Anne Helene ; Schwartz, Walter ; Vejborg, Ilse ; Lynge, Elsebeth. / Predicting the risk of a false-positive test for women following a mammography screening programme. In: Journal of Medical Screening. 2007 ; Vol. 14, No. 2. pp. 94-7.

Bibtex

@article{eee08e30b24e11ddb04f000ea68e967b,
title = "Predicting the risk of a false-positive test for women following a mammography screening programme.",
abstract = "OBJECTIVES: The objectives of this study was to provide a simple estimate of the cumulative risk of a false-positive test for women participating in mammography screening. To test the method, we used data from two well-established, organized mammography screening programmes offering biennial screening to women aged 50-69 years in Copenhagen and Fyn, Denmark. METHODS: We defined the outcome from a screen as being either a false-positive test or not a false-positive test. We then tested whether the outcomes from subsequent screens were independent, and afterwards estimated the risk over 10 screens of a false-positive test, i.e. the risk of getting at least one false-positive test for a woman participating in all 10 screens typically offered in Europe. RESULTS: The outcomes of subsequent screens were found to be independent. After completion of screening rounds 3-5, the risk of a false-positive test over 10 screens was predicted to be 15.8-21.5% for a woman participating in the programme in Copenhagen, and 8.1-9.6% for a woman participating in the programme in Fyn. CONCLUSIONS: Our study showed that a relatively robust prediction of the risk of a false-positive test over 10 screens can be calculated in a simple way relatively early after the start of a mammography screening programme.",
author = "Njor, {Sisse Helle} and Olsen, {Anne Helene} and Walter Schwartz and Ilse Vejborg and Elsebeth Lynge",
note = "Keywords: Aged; Breast Neoplasms; Denmark; False Positive Reactions; Female; Humans; Mammography; Mass Screening; Middle Aged; Risk Factors",
year = "2007",
doi = "10.1258/096914107781261891",
language = "English",
volume = "14",
pages = "94--7",
journal = "Journal of Medical Screening",
issn = "0969-1413",
publisher = "SAGE Publications",
number = "2",

}

RIS

TY - JOUR

T1 - Predicting the risk of a false-positive test for women following a mammography screening programme.

AU - Njor, Sisse Helle

AU - Olsen, Anne Helene

AU - Schwartz, Walter

AU - Vejborg, Ilse

AU - Lynge, Elsebeth

N1 - Keywords: Aged; Breast Neoplasms; Denmark; False Positive Reactions; Female; Humans; Mammography; Mass Screening; Middle Aged; Risk Factors

PY - 2007

Y1 - 2007

N2 - OBJECTIVES: The objectives of this study was to provide a simple estimate of the cumulative risk of a false-positive test for women participating in mammography screening. To test the method, we used data from two well-established, organized mammography screening programmes offering biennial screening to women aged 50-69 years in Copenhagen and Fyn, Denmark. METHODS: We defined the outcome from a screen as being either a false-positive test or not a false-positive test. We then tested whether the outcomes from subsequent screens were independent, and afterwards estimated the risk over 10 screens of a false-positive test, i.e. the risk of getting at least one false-positive test for a woman participating in all 10 screens typically offered in Europe. RESULTS: The outcomes of subsequent screens were found to be independent. After completion of screening rounds 3-5, the risk of a false-positive test over 10 screens was predicted to be 15.8-21.5% for a woman participating in the programme in Copenhagen, and 8.1-9.6% for a woman participating in the programme in Fyn. CONCLUSIONS: Our study showed that a relatively robust prediction of the risk of a false-positive test over 10 screens can be calculated in a simple way relatively early after the start of a mammography screening programme.

AB - OBJECTIVES: The objectives of this study was to provide a simple estimate of the cumulative risk of a false-positive test for women participating in mammography screening. To test the method, we used data from two well-established, organized mammography screening programmes offering biennial screening to women aged 50-69 years in Copenhagen and Fyn, Denmark. METHODS: We defined the outcome from a screen as being either a false-positive test or not a false-positive test. We then tested whether the outcomes from subsequent screens were independent, and afterwards estimated the risk over 10 screens of a false-positive test, i.e. the risk of getting at least one false-positive test for a woman participating in all 10 screens typically offered in Europe. RESULTS: The outcomes of subsequent screens were found to be independent. After completion of screening rounds 3-5, the risk of a false-positive test over 10 screens was predicted to be 15.8-21.5% for a woman participating in the programme in Copenhagen, and 8.1-9.6% for a woman participating in the programme in Fyn. CONCLUSIONS: Our study showed that a relatively robust prediction of the risk of a false-positive test over 10 screens can be calculated in a simple way relatively early after the start of a mammography screening programme.

U2 - 10.1258/096914107781261891

DO - 10.1258/096914107781261891

M3 - Journal article

C2 - 17626709

VL - 14

SP - 94

EP - 97

JO - Journal of Medical Screening

JF - Journal of Medical Screening

SN - 0969-1413

IS - 2

ER -

ID: 8592589